share_log

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

4：持股變動聲明-董事 McNealey Jennifer Isacoff
美股SEC公告 ·  05/16 04:55
牛牛AI助理已提取核心訊息
Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
與Conduit Pharmicals有聯繫的詹妮弗·艾薩科夫·麥克尼利於2024年5月13日參與了一項涉及該公司股票的交易。該交易的具體細節，包括股票數量、股票的性質、交易價格和股票的總價值，尚未披露。公告中也沒有提供行動類型和狀態以及McNealey在交易後持有的股票數量。
與Conduit Pharmicals有聯繫的詹妮弗·艾薩科夫·麥克尼利於2024年5月13日參與了一項涉及該公司股票的交易。該交易的具體細節，包括股票數量、股票的性質、交易價格和股票的總價值，尚未披露。公告中也沒有提供行動類型和狀態以及McNealey在交易後持有的股票數量。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。